Allostery Investments LP 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:05 pm Sale | 2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Allostery Investments LP | 55,840 0.500% | -22,415 (-28.64%) | Filing |
| 2024-05-13 12:38 pm Purchase | 2024-05-01 | 13G | Avalo Therapeutics, Inc. AVTX | Allostery Investments LP | 78,255 7.600% | 78,255 (New Position) | Filing |